Merrimack Pharmaceuticals Inc. has signed a lease for a bit less than 110,000 square feet of space at One Kendall Square in Cambridge, said a broker involved in the transaction.
The broker is Colliers International, which represented Merrimack in the lease negotiations. The lease represents a 25,000 square foot expansion for Merrimack. The firm Cassidy Turley FHO represented the landlord, the Beal Cos., in lease negotiations.
A biopharmaceutical company, Merrimack looks to commercialize innovative medicines paired with companion diagnostics for the treatment of serious diseases, with an initial focus on cancer.